Skip to main content
. 2023 Feb 23;24(5):4440. doi: 10.3390/ijms24054440

Figure 7.

Figure 7

Clinical utility of the molecular results yielded by ALLseq. (A) Heat map identifying patients for whom useful alterations for diagnosis, risk stratification, and/or targeted therapy selection was found. (B) Circos diagram generated from the heat map data. (C) Percentage of patients that can benefit from molecular results when ALLseq and/or cytogenetics (CTG) are used.